Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers

Amphiphysin Antibody

Amphiphysin antibodies are autoantibodies produced by the immune system that mistakenly target proteins called amphiphysins, which are involved in regulating the function and structure of nerve cells. When these antibodies are present, they can be indicative of paraneoplastic syndrome, a group of signs and symptoms that occur in some people with cancer. Paraneoplastic syndrome is not caused by the primary tumor or its metastases, but rather by the immunological response to the tumor. The amphiphysin antibody test is used to aid in the diagnosis of paraneoplastic syndromes, especially in patients with breast cancer and small cell lung cancer. This test is essential as paraneoplastic syndromes can affect various systems and mimic other diseases.

  • Test NameAmphiphysin Antibody (for Paraneoplastic Syndrome)
  • Sample TypeBlood (serum)
  • Preparations RequiredNo special preparations are required for this test. Continue taking regular medications unless specifically instructed otherwise by the doctor.
  • Report Time24 hours

What are Amphiphysin Antibodies?

Amphiphysin antibodies are autoantibodies that target amphiphysin proteins. These proteins are primarily involved in synaptic vesicle endocytosis in nerve cells. The antibodies can be associated with paraneoplastic syndromes, which are disorders triggered by an abnormal immune response to a cancerous tumor known as a neoplasm.

What is Paraneoplastic Syndrome?

Paraneoplastic syndrome consists of signs and symptoms that occur in individuals with cancer but are not directly related to the physical effects of the cancer itself. It is thought to result from the body’s immune response to the tumor or secretions from the tumor affecting other organs.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

The Amphiphysin Antibody test is primarily done to assist in the diagnosis of paraneoplastic syndromes in patients with breast cancer and small cell lung cancer. It can also help in determining the cause of neurological symptoms such as muscle weakness, numbness, or cognitive changes in a person with known or suspected cancer.

If Amphiphysin Antibodies are detected in your blood, it may suggest the presence of a paraneoplastic syndrome, especially if you have a known diagnosis of cancer. This can cause various symptoms and affect different organs, especially the nervous system.

Symptoms of paraneoplastic syndrome can vary widely but often include neurological symptoms such as difficulty walking, loss of muscle coordination, or cognitive changes. Other symptoms can include fever, fatigue, weight loss, and skin changes.

A healthcare professional will collect a blood sample from a vein, usually in your arm.

Treatment focuses on addressing the underlying cancer and managing symptoms. Immunotherapy, plasmapheresis, and medications to suppress the immune system may also be used to treat the autoimmune aspect of paraneoplastic syndrome.

While Amphiphysin Antibodies are typically associated with paraneoplastic syndromes and cancer, they can sometimes be present in low levels in individuals without cancer.

You should see an oncologist or a neurologist if you have positive Amphiphysin Antibodies. The oncologist will address the underlying cancer, and the neurologist will help manage any neurological symptoms.

There is no cure for paraneoplastic syndrome, but treatments can help manage the symptoms. The most effective treatment is to control the underlying cancer.

Cancer can cause paraneoplastic syndrome by triggering an abnormal immune response. In some cases, proteins produced by the tumor resemble proteins in other parts of the body, causing the immune system to attack these areas.

Paraneoplastic syndrome itself isn't usually fatal, but it can cause serious or life-threatening complications. The underlying cancer is often a more critical factor in the patient's prognosis.

Having breast cancer or small cell lung cancer increases the risk of developing Amphiphysin Antibody-related Paraneoplastic Syndrome. The reason some people with these cancers develop the syndrome is not entirely understood.

Yes, Amphiphysin Antibody levels can change over time, especially with treatment for cancer or the autoimmune aspects of paraneoplastic syndrome.

The outlook for a person diagnosed with Paraneoplastic Syndrome due to Amphiphysin Antibodies varies depending on the underlying cancer and the severity of the syndrome. Early diagnosis and management of both the cancer and the paraneoplastic syndrome are crucial for improving quality of life.

Understanding and managing paraneoplastic syndromes, such as those associated with Amphiphysin Antibodies, is vital. It is important for patients to work closely with their doctors to monitor and manage the symptoms effectively, as well as focus on treating the underlying cancer. Combining cancer therapy with treatments aimed at alleviating the symptoms of the paraneoplastic syndrome can enhance the patient's well-being and quality of life.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet